Beacon Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Beacon Trust's BMY Position: Q1 2017 in Review
Beacon Trust reduced its Bristol-Myers Squibb (BMY) stake by 5.2% in Q1 2017, selling an estimated $145K and leaving 48,559 shares worth $2.75M. The position accounts for 0.43% of the portfolio, ranked #80.
Beacon Trust first reported a position in BMY in Q2 2013 and has held it in 16 quarters since. The position peaked at $13.6M in Q3 2013. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- Beacon Trust held 48,559 shares of Bristol-Myers Squibb worth $2.75M as of Q1 2017.
- Beacon Trust sold 2,652 Bristol-Myers Squibb shares in Q1 2017, an estimated $145K.
- Bristol-Myers Squibb made up 0.43% of Beacon Trust's portfolio in Q1 2017, its #80 holding.
- Beacon Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 16 quarters since.
- Beacon Trust's Bristol-Myers Squibb position peaked at $13.6M in Q3 2013.
- 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.